Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 1,203 shares at $26.51 ($32K) on 2026-01-07, disclosed to the SEC on 2026-01-09.
Open-market sale of $32k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.51 | 1,148 | $30K | 95.4% |
| 2 | $26.92 | 55 | $1K | 4.6% |
| Total | $26.53 avg | 1,203 | $32K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |